Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes

Targeted busulfan/cyclophosphamide ((T)BU/CY) for allogeneic hematopoietic cell transplantation (HCT) carries a high risk of sinusoidal obstruction syndrome (SOS) in patients transplanted for myelofibrosis. We tested the hypothesis that reversing the sequence of administration (from (T)BU/CY to CY/(...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rezvani, Andrew R., McCune, Jeannine S., Storer, Barry E., Batchelder, Ami, Kida, Aiko, Deeg, H. Joachim, McDonald, George B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3898851/
https://ncbi.nlm.nih.gov/pubmed/23583825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2013.04.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados